CPT1B: Carnitine O-palmitoyltransferase 1, muscle isoform
Catalyzes the transfer of the acyl group of long-chain fatty acid-CoA conjugates onto carnitine, an essential step for the mitochondrial uptake of long-chain fatty acids and their subsequent beta-oxidation in the mitochondrion. .
- Drugs that act on it: 1
- Approved: 1
- In phases 1 to 3: 0
- Sponsors: 1
Who is on it, and how far along
Every drug ChEMBL records acting on CPT1B, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 1
| Drug | Furthest stage | Sponsor | Modality | Action | Open trials |
|---|---|---|---|---|---|
| PerhexilineWithdrawn | Approved | Heart Metabolics Limited | Small molecule | InhibitorCarnitine O-palmitoyltransferase 1, muscle isoform inhibitor | 0 |
- Cardiovascular disorder0.37
- Angina pectoris0.37
- Left ventricular hypertrophy0.20
- Hypertrophic cardiomyopathy0.16
- Heart failure0.16
- Pathological myopia0.11
- Myopia0.11
- Colorectal carcinoma0.08
- Lagophthalmos0.08
- Myasthenia gravis0.07
- Diabetes mellitus0.06
- Dilated cardiomyopathy0.06
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2216739, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. Gene name, function (UniProt Q92523, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets